(We are targeting applicants of all genders)
Part Time 65% | limited for 2 years | Announcement number: 1000-2024
Join our dynamic research group dedicated to advancing the field of neurooncology as a PhD student. The Translational Neurooncology Junior Group, funded by the Mildred Scheel Early Career Center (MSNZ) and the Frankfurt Cancer Institute (FCI) is under the supervision of Dr. Ann-Christin Hau and Dr. Tanja Müller.
Affiliated with the Dr. Senckenberg Institute of Neurooncology and the Neurological Institute (Edinger Institute) of the Goethe University Hospital Frankfurt am Main, our team is at the forefront of pre-clinical research. Our group contributes to the evolvement of patient-derived models of primary brain tumors, developing them for genetic (CRIPR-Cas) and pharmaceutical screens through live cell imaging. Our commitment lies in unravelling the molecular mechanisms of tumor evolution and tumor invasion, with the ultimate goal of advancing understanding and treatment of these complex diseases.
We are looking for you to join our team as soon as possible.
Research Topic: Join us as we confront glioblastoma, a challenging primary brain tumor known for its high recurrence rates and grim prognosis. Our advertised PhD project focuses on developing a pioneering pre-clinical ex vivo glioblastoma organoid model using relapsed tumor samples. We integrate patient-specific tissue, immune cells, and genetically engineered HER2-specific CAR-NK cells to explore innovative treatment avenues. Traditional therapies struggle against glioblastoma's immunosuppressive microenvironment. Our organoid model aims to inspire the development of novel immunotherapeutic strategies. To bolster the reliability of our findings, we’ll validate our research using immunocompetent mouse models, particularly humanized mice. Additionally, we have the unique opportunity to contribute to the ongoing CAR2BRAIN study, the first -in-human clinical trial using NK cells. This ensures our work translates effectively, to clinical settings, potentially improving outcomes for patients. Join us and be a part of meaningful change!
For an insight into the University Hospital Frankfurt, click here.